Analysis of bevacizumab (Bev) therapy, bisphosphonate use and osteonecrosis of the jaw (ONJ) in > 1900 patients treated in two randomized, controlled trials. - Guarneri,V.; Miles,D.; Robert,N.J. (Cancer Res, 2009)